From passive to active: will recombinant growth factor therapeutics revolutionize regeneration?
Wisner-Lynch
Leslie A
LA
D001861:Bone Regeneration / Q000187:drug effects*; D016503:Drug Delivery Systems; D006133:Growth Substances / Q000494:pharmacology*; D016557:Guided Tissue Regeneration, Periodontal; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D011994:Recombinant Proteins / Q000494:pharmacology*; D023822:Tissue Engineering
D006133:Growth Substances; D047908:Intracellular Signaling Peptides and Proteins; D011994:Recombinant Proteins